Mohamad Farouk

• Oversaw operations and provided corrective feedback to achieve daily and long-term goals.
• Increased overall company performance by 25% by implementing strategic management initiatives and streamlining operations.

• Re-organizing the pages (transitional period)

• Acting As An Associate Dir, Marketing, Biosimilars & Sterile Injectables
• Led a rebranding initiative that resulted in improved consumer perception and increased sales revenue by 15%.
• A Biosimilars Saudi Lead, to accomplish and reassess the assigned tasks
• Develop fresh marketing strategies for the Biosimilars portfolio by visiting markets to meet customer demands
• Foster innovation, customer focus, and personal accountability and achieve desired results
• Arrange weekly and monthly internal customer insights meetings with staff members to discuss issues related to the commercial plan
• Key Accomplishments: Built robust updated short and LRF for the BS portfolio with high acceptance from the area president(Ref Available) parallel to redefine the go-to-market strategy & marketing strategy of the Biosimilar portfolio Ensured programs, tools, and materials readiness for team (The Bio-Rovers) utilization in the SA market
• Extend the support to the Gulf area, with the result of 120% Ach TMS

• Increased overall business efficiency by streamlining operational processes and implementing cost-saving measures.10% increase direct to the bottom line.
• Conducted thorough market research to identify emerging trends and opportunities for the company growth in Saudi Arabia.(within Vision 2023)
• Served as a key liaison between executive leadership and team members, fostering open communication channels and addressing concerns promptly.
• Cultivated strong relationships with vendors, suppliers, and other external stakeholders to optimize collaboration efforts and achieve mutual benefits.

I successfully designed and implemented a comprehensive corporate strategy in collaboration with the CM, this included directing and planning key corporate strategies, as well as organizing high-profile communication events such as the Pfizer plant grand opening and the annual Plan of Action (POA).

I led the negotiation process with potential business partners and crafted a detailed execution plan to finalize impactful deals. My efforts culminated in the creation of a strategic business development plan aimed at enhancing revenue streams for the company.

I directed and endorsed projects within a complex matrix structure, effectively managing both internal and external stakeholders, including investors. Through my proactive approach,

I identified, evaluated, and prioritized new investment opportunities, compiling an initial list of potential alliances, joint ventures (JVs), and partnership targets to foster growth and drive the organization forward.

Key Accomplishments:
Awarded a 6-month assignment as Director of Business Operations, where I demonstrated strong leadership and strategic vision by establishing precise KPIs and backup plans to ensure effective goal achievement.
Milestones:
- Achieved a 10% increase in the company's bottom line.
- Revised contracts with distributors and outsourcing channels.
- Recognized for developing the 2019 country operating plan, including a transformation strategy.
- Restructured the organization to optimize efforts following two layoffs.
- Created and executed a change management plan for 2019.
- Led the MEGA-16 project from signature to closing by effectively managing processes, manpower, and coordination with Pfizer sites and Pfizer Global Supply (PGS).
- Planned and directed corporate strategies and communication events, including the Pfizer plant grand opening and annual POA strategy implementation.
- Launched 10 new products in one year through dedicated efforts at regional and country levels.

• Key Accomplishments: Led a team of 1 national sales manager, 4 sales managers, and 2 field trainers, for 14 months across the kingdom, achieved 120% with 30% G over the former year
• Pfizer's portfolio achieves an average of 118% achievements, with 37% G in TMS.

• Official Position Summary : Forecast and Manage portfolio performance (Sales and Supply)
• Leverages Regional EP Leads, Commercial Solutions Center expertise, and TA expertise/content as needed Develop channel-specific approaches for key customer segments (e.g., retail, hospitals, governments, etc.) Craft and execute strategies to promote EP product portfolio (e.g., messaging, product grouping, relevant collateral, assess and prioritize, etc.) Develop local market life-cycle strategies (i.e
• Line extension, new indications) by collaborating with stakeholders in other Commercial Units Provide market insights to relevant Senior Regional EP Leads Highlight and support opportunities for local partnerships, in collaboration with the in-country CU Lead
• Serves as a local marketing expert for key non-HCP customer segments Engage in brand-specific campaigns (e.g., reminder campaigns or occasional content refreshes)
• Key Responsibilities:
• Accountable Achieve and influence the development of country sales targets, OP plan Assess revenue potential for product portfolio Execution of sales and marketing strategy and portfolio POA, Develop sales materials
• Obtain final regulatory/legal approval of tactical portfolio plan Align with a customer / Access plan
• Shared Accountabilities Explore opportunities for cross-selling between EP and in-line products (w/ CBL and FF) Surface opportunities for value-add activities (with Customer Marketers in the country) Identify and pursue opportunities for local deals (w/ in-country CU Lead) Development of revenue targets for portfolio

• Key Accomplishments :
• Relaunched the AI portfolio with 37% growth over 5 years, contributing from 8% to 35% from the AFME TMS sales
• Bestowed with the Individual Performance Award recognition letter for demonstrating excellence in the areas of excellence and collaboration across countries and CPNs (Community Practice Networks) on the Emerging Markets Established Products Business Unit level
• Awarded by Vice President of EPEM, Marketing Director, AI EP, Emerging Markets, Pfizer Inc. NY, Director Anti Invectives' and Hospital Business, EPBU, Pfizer Inc, NY, Sr Regional Director-Established products, Medical Director, Saudi Arabia, Country Manager, Saudi Arabia, 2012 Awarded with the Best Product Manager award by the STAR AWARD Program
• 2011 Contributed to product planning, defining roadmaps, and developing new ideas for supporting future product development and achieving sales targets like [Monofer]

• Key responsibilities : Directed, examined and assessed the sales team's overall activities to prepare employee progress reports
• Generated an appropriate follow-up system for the sales team to supervise the performance of staff and encouraged the sales team to complete sales targets
• Increased sales, volume distribution, customer service by developing and implementing business development measures.
• Recommended/advised changes in business model by calculating/evaluating customer's feedback on survey forms
• Examined and researched the existing market situation, captured new business opportunities, prepared reports by analyzing and forecasting gathered information, and forwarded them to the sales director for decision-making
• Optimized product penetration in the market by developing a vision and commercial plan of the product as well as implementing new marketing strategies

• Established strong relationships with healthcare professionals, resulting in increased trust and credibility for the organization.
• Analyzed market to identify new opportunities and strengthen relationships with hospitals, medical centers and primary provider physicians.(120% Sales Ach.)

• Supported sales representatives during client meetings by providing expert knowledge on specific features or functionalities of Avandia.
• Achieved 120% Sales.